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rimary care physicians diagnose and care for a significant portion of the millions of Americans with asthma and COPD. 1 Yet, debate continues regarding the appropriateness, value, and barriers related to in-office spirometry in primary care practices for management of obstructive lung diseases. [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] Studies show that technically adequate spirometry is possible, 6 that screening spirometry of all primary care patients who smoke can identify COPD and modify some COPD treatment, 15, 16 and that spirometry in children can be interpreted in primary care practices. 17 A vignette study 18 suggests that family physicians would use spirometry results to modify management of COPD, but no study has
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assessed the impact of incorporating spirometry into the everyday management of family medicine patients with existing diagnoses of asthma or COPD.
We introduced office spirometry into 12 communitybased family medicine practices scattered through-out the United States to assess the impact of onsite spirometry in the management of previously diagnosed COPD or asthma. We also assessed thetechnical adequacy and accuracy of interpretation of the tests performed. This real-world study adds another dimension to published data 6, 11, [15] [16] [17] 19, 20 from other countries.
Materials and Methods
Using a before-and-after quasiexperimental design, spirometers (Easy One; ndd Medizintechnik AG; Zurich, Switzerland) were introduced into 12 nonacademic family medicine practices without prior use of in-office spirometry. The practices were randomly selected from 35 of the 112 practices of the American Academy of Family Physicians National Research Network that volunteered for this study. 21, 22 From each practice, a physician and the person who would administer spirometry participated in an intensive 2-day training session on performance and interpretation of spirometry led by authors E.I., R.L., P.E., B.Y., and S.S.
The Easy One device was chosen for its modem capacity and stability precluding the requirement of daily calibration. 23 The output was standardized: single "best flow volume loop", FEV 1 and FVC in milliliters and percentage of predicted, the FEV 1 / FVC ratio, 24 -27 a grade of the technical adequacy (A through F), and a suggested interpretation of the results. FVC was used in preference to forced expiratory volume in 6 s due to the inclusion of children in the study who frequently reach a plateau prior to 6 s of expiration. 28 After receiving institutional review board approval, each site spent the next 6 months enrolling patients Ͼ7 years old with a previously documented diagnosis of asthma or COPD and were attending the office for an asthma-or COPD-related visit. Thus, spirometry was incorporated into everyday practice rather than being used only as a research tool or screening add-on or a test requiring referral. 15, 16, 19 Prior lung function testing was not required to confirm the diagnosis of asthma or COPD. Only two patients refused to participate.
Enrolled patients provided demographic and disease-related information including current symptoms, perceived severity, and level of disease control. Nursing staff documented current medications on the study forms. Physician visits proceeded as usual without the use of spirometry, and at the end of the visit the physician documented the therapy recommended that day using a list of the common asthma and COPD medications with ranges of dosages. This was the "before" data.
The patient then underwent spirometry, and a copy of the results was reviewed by the family physician who recorded his/her interpretation of the results on the study forms. The physician again saw the patient (during the same visit) for a quick follow-up to discuss test results and make any desired changes to the management plan, which were recorded on the "after" section of the study forms using a medication checklist and for nonmedication changes answering the question: "Would you make any nonmedication changes after seeing the spirometry results? If yes, please describe." Responses included "more frequent follow-up," "referral to evaluate a non-COPD diagnosis," or "repeat spirometry testing in 3 months." A combination of patient-provided symptom information, spirometry results, and before-and-after medications allowed us to judge whether the medications appeared to be consistent or inconsistent with National Asthma Education and Prevention Program 24 or Global Initiative for Chronic Obstructive Lung Disease 25 guidelines.
Copies of the spirometry results and the family physician's interpretation were sent to one of the experts for their review and scoring. Technical adequacy of all tracings was scored by P.E. based on published American Thoracic Society and European Respiratory Society criteria as adequate or inadequate. 23, 26, 27 The family physician's interpretation was assessed as concordant or nonconcordant with the expert's review (R.L, E.I. or H.B) based on standard criteria for obstruction, restriction, and asthma. 24, 29 "Nonconcordant" results were further subclassified into "obstruction reported but not present," "obstruction present but not reported," "obstruction less severe than reported," or "other abnormality present but not reported." The concordance between the Easy One reading and the expert review was also assessed.
Statistical Analysis
Simple descriptive statistics were used to assess rates of management change by comparing before-and-after data for medications and nonmedication management, rates of technical adequacy, and rates of agreement. Rates of nonconcordance were compared using 2 and Mantel Haenzel tests.
Results
The 12 practice investigators were all family physicians working in communities with populations Յ100,000. The 382 patients were mainly women (63%) and adults (76%) with a mean age of 46.1 years (SD, 19.9 years; range, 7 to 89 years). Overall, 248 patients (65%) had a previous diagnosis of asthma only, 100 patients (26%) had COPD only, and 32 patients (8%) had both asthma and COPD.
Of the 382 patients, 2 patients withdrew before testing and 12 others never completed a test maneuver. Ten of these 12 patients were Ͻ9 years old (n ϭ 4) or Ͼ70 years old (n ϭ 6). Of the 368 completed tests, 261 tests (71%) were considered to be technically "good" (Fig 1, 2 results were not reproducible; in 16 tests (4%), the best maneuver was Ͻ4 s in duration and did not reach a plateau; and in 25 tests (7%), the best maneuver showed a slow start. Among the group of subjects with nonreproducible maneuvers, 13 tests had one result that was technically good and interpreted as normal. The percentage of tests that were reproducible and technically adequate varied by practice site (p ϭ 0.045 for a difference in rates of technical adequacy among practices) [Fig 2] , with 7 of the 12 sites having technical adequacy rates Ͼ80%.
Interpretations of the spirometry results were concordant in 280 patients (76% of all completed tests) [ Table 1 ; Fig 2] , including 28 tests rated as "not interpretable" by both the family physician and the lung specialist. The percentage of nonconcordance was higher in people with prior COPD diagnoses compared to those with prior asthma diagnoses (30.0% vs 19.8%, respectively; p Ͻ 0.05; Table 1 ). Common types of nonconcordance included overreporting of airflow obstruction in those with normal spirometry results, interpreting restrictive patterns in people with poor effort, and an affirmation of COPD in the absence of an FEV/FVC ratio Ͻ70% (Table 1) . Approximately 3% of the spirometry tracings had complex or combination abnormalities (such as restriction combined with obstruction) that the family physician often did not even attempt to interpret except as "unknown" or "abnormal."
ndd Medizintechnik AG and the expert review were concordant in 93.7% of tests. All but one of the nonconcordant interpretations were read as "restrictive pattern" by ndd Medizintechnik AG, but the experts determined the tests to be inadequate due to poor effort. Comparing before-and-after data demonstrated 207 reported changes in management in 182 of the 382 patients tested (48%), with decisions in 186 of 207 patients based on technically accurate and correctly interpreted tests (Fig 2) . Over half (n ϭ 107, 51.6%) were changes in medications that are described in Table 2 . Most medication increases were for "mild" disease reclassified as moderate or severe asthma or COPD after spirometry assessment. Normal spirometry results were associated with six medication decreases or discontinuations.
Overall, 86% of the medication changes were consistent with the Global Initiative for Chronic Obstructive Lung Disease guidelines 25 for COPD management or the 2002 National Asthma Education and Prevention Program guidelines 30 for asthma management. Two thirds of the medication changes that appeared to be inconsistent with guidelines ‫ء‬Data are presented as No. of times that interpretation agreed or differed from the family physician's interpretation (%). †Of these seven patients, five had restrictive disease and two had combined restrictive and obstructive disease. were made following technically inadequate or incorrectly interpreted spirometry results. Nonmedication management changes were made in 102 patients, 75 not associated with medication changes and 27 with a coincident change in medications (Table 2 ). Of particular note are the 19 patients referred for other potential diagnoses following normal spirometry findings, and 28 patients who were referred for co-management of severe obstructive lung disease.
Discussion
Incorporation of spirometry testing into these family medicine practices led to spirometry testing with acceptable levels of technical quality and concordant interpretation and was followed by management changes for almost half of the patients. Poor technical quality and low rates of concordant interpretations were limited primarily to two practices (G and J in Fig 2) .
Our results support previous work 6,11,17,30 -32 demonstrating moderate-to-high levels of technical adequacy and ability to accuracy interpret spirometry in primary care. Specifically, in Dutch general practices, a rate of technical adequacy of 82% was reported. 6, 31 In 10 general pediatrician offices in Italy, 78% of the 109 tests were of technically good quality. 17 These are much higher than the technical adequacy rates of 52 to 66% reported in earlier studies 5, 33 from general practitioner offices. Part of the improvement in technical adequacy may be a result of the newer spirometry equipment that grades each spirometry effort, providing immediate feedback related to technical adequacy. No threshold of technically acceptable rates has been established for primary care practices. 5, 14, 26, 34 While the standards reported from the Lung Health Study 35 are optimal, it appears that rates closer to 80% technical adequacy are more realistic for both primary care and pulmonary function laboratories. 6, 17 Reproducibility was a major barrier to technical adequacy in our study, including 13 patients who had a single normal spirometry finding but could not repeat the results. Normal but nonreproducible results can be useful in guiding therapy 36 and would push our rates of clinically useful and interpretable spirometry to 75%. The addition of the complex studies that the family physicians correctly decided not to attempt to interpret push accuracy rates to 78%. Another important reason for nonconcordant readings were tests that experts suggested had inadequate effort that both the family physician and ndd Medizintechnik AG interpreted as "restrictive patterns" (n ϭ 21). In these cases, ndd Medizintechnik AG was not helpful in suggesting interpretation of results.
Two sites with the poorest technical performance (G and J in Fig 2) reported that multiple nurses and medical assistants performed spirometry despite not being trained in spirometry techniques. The high rates of technical adequacy in the majority of the sites are reassuring, but problems in the sites using untrained staff highlight the need for simple, inexpensive, interactive education tools for spirometry performance. 8, 27, 37 The reasons for the low concordance of interpretation of the results in the same two sites with poor technical quality are unknown. Each site received individual feedback from specialists at the end of the study.
Few studies in the literature have assessed the 18 used vignette studies with spirometry data to conclude that spirometry had an impact on primary care clinical decision making. A study 38 of nurse-based protocol care reported that spirometry affected decision making in only 4% of 109 cases but assessed only the impact of worsening FEV 1 .
In our study, both normal and abnormal results appeared to be useful in determining the care for patients with asthma and COPD diagnoses. For example, 18 adults with COPD had normal spirometry results suggesting that their breathing symptoms were not due to COPD. 25 Three patients were referred to cardiologists for further evaluation, five patients were referred to pulmonologists for further testing, and the others were scheduled for further evaluation in the primary care office. Unlike the high rate of "overprescribing" reported by Walker et al, 19 most of the medication changes reported appeared to be consistent with guidelines. This may be due to greater current awareness of guidelines and concerns about over use of medications.
Generalization of our results is limited by the sample size of only 12 family physician practices. Our study should be repeated with a larger group of practices. However, similar findings in other studies 5, 6, 17, 31 using different designs reinforce our practice-based data. We assessed the impact of only the first spirometry for these patients and therefore cannot assess the impact of repeated spirometry in chronic management of obstructive lung disease. Not requiring spirometry confirmation of all COPD diagnoses for patient inclusion in the study is likely to have increased the number of people found to not have COPD on spirometry. 25 In addition, the physicians knew they were part of a research study and may have overreported changes in clinical practice. However, this overreporting would have had to last for 6 months, and few studies have shown the ability to modify physician behavior over such an extended period of time. In summary, our study demonstrates that spirometry can be incorporated into family medicine practice with acceptable levels of technical adequacy and accurate interpretations, and that the results influence management of patients with previously diagnosed asthma or COPD.
